- Home
- YHGJ vs ADVB Comparison
YHGJ vs ADVB Comparison
Compare YHGJ & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YHGJ
- ADVB
- Stock Information
- Founded
- YHGJ 1975
- ADVB 2014
- Country
- YHGJ United States
- ADVB United States
- Employees
- YHGJ N/A
- ADVB N/A
- Industry
- YHGJ Specialty Chemicals
- ADVB Medical Specialities
- Sector
- YHGJ Industrials
- ADVB Health Care
- Exchange
- YHGJ Nasdaq
- ADVB Nasdaq
- Market Cap
- YHGJ 22.5M
- ADVB 20.8M
- IPO Year
- YHGJ 1997
- ADVB 2025
- Fundamental
- Price
- YHGJ $0.75
- ADVB $0.64
- Analyst Decision
- YHGJ
- ADVB
- Analyst Count
- YHGJ 0
- ADVB 0
- Target Price
- YHGJ N/A
- ADVB N/A
- AVG Volume (30 Days)
- YHGJ 7.3K
- ADVB 86.3K
- Earning Date
- YHGJ 05-20-2025
- ADVB 08-03-2025
- Dividend Yield
- YHGJ N/A
- ADVB N/A
- EPS Growth
- YHGJ N/A
- ADVB N/A
- EPS
- YHGJ N/A
- ADVB N/A
- Revenue
- YHGJ $17,861,000.00
- ADVB N/A
- Revenue This Year
- YHGJ N/A
- ADVB N/A
- Revenue Next Year
- YHGJ N/A
- ADVB N/A
- P/E Ratio
- YHGJ N/A
- ADVB N/A
- Revenue Growth
- YHGJ 1.21
- ADVB N/A
- 52 Week Low
- YHGJ $0.43
- ADVB $0.56
- 52 Week High
- YHGJ $1.43
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- YHGJ 42.94
- ADVB N/A
- Support Level
- YHGJ $0.71
- ADVB N/A
- Resistance Level
- YHGJ $0.85
- ADVB N/A
- Average True Range (ATR)
- YHGJ 0.08
- ADVB 0.00
- MACD
- YHGJ 0.00
- ADVB 0.00
- Stochastic Oscillator
- YHGJ 22.64
- ADVB 0.00
About YHGJ Yunhong Green CTI Ltd.
Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.